{
    "clinical_study": {
        "@rank": "89062", 
        "arm_group": [
            {
                "arm_group_label": "Drag: Crystalloids and Colloids", 
                "arm_group_type": "Active Comparator", 
                "description": "Drag: Crystalloids and Colloids Intraoperative 10 ml/kg/per hour, postoperative 70-100 ml/per hour"
            }, 
            {
                "arm_group_label": "Standard fluid regime", 
                "arm_group_type": "Experimental", 
                "description": "Drag: Crystalloids and Colloids Intraoperative 15 ml/kg/per hour, postoperative 150-200 ml/per hour"
            }
        ], 
        "brief_summary": {
            "textblock": "Elective minilaparatomy abdominal aortic aneurysm (AAA) repair is associated with a\n      significant number of complications involving respiratory, cardiovascular, gastrointestinal\n      and central nervous system, and mortality ranging up to 5%. In our study, we tested the\n      hypothesis that intraoperative and postoperative intravenous restrictive fluid regime\n      reduces postoperative morbidity and mortality and improves the outcome of the treatment of\n      minilaparotomy AAA repair."
        }, 
        "brief_title": "Restrictive Versus Standard Fluid Regime in Elective Minilaparotomy Abdominal Aortic Aneurysm Repair", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Abdominal Aortic Aneurysm > 5.5 cm Effect of a Restricted Intravenous Fluid Regime on Complications and Hospital Stay After the Minilaparotomy AAA Repair.", 
        "condition_browse": {
            "mesh_term": [
                "Aneurysm", 
                "Aortic Aneurysm", 
                "Aortic Aneurysm, Abdominal"
            ]
        }, 
        "detailed_description": {
            "textblock": "We investigate effects of a restricted fluid regime versus standard regimen on complications\n      and hospital stay after minilaparatomy aortic aneurysm repair."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  AAA more than 5,5 cm in diameter tube graft\n\n        Exclusion Criteria:\n\n          -  emargency comorbidity maligancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "July 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01939652", 
            "org_study_id": "UKCTUZLA"
        }, 
        "intervention": [
            {
                "arm_group_label": "Drag: Crystalloids and Colloids", 
                "intervention_name": "Restrictive VS Standard Fluid Regime", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Standard fluid regime", 
                "intervention_name": "Drag: Crystalloids and Colloids", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "minilaparotomy", 
            "AAA", 
            "fluid regime"
        ], 
        "lastchanged_date": "September 5, 2013", 
        "number_of_arms": "2", 
        "official_title": "Restrictive Versus Standard Fluid Regime in Elective Minilaparotomy Abdominal Aortic Aneurysm Repair", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Bosnia: Federal Ministry of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Number of major and minor complications", 
            "safety_issue": "Yes", 
            "time_frame": "30 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01939652"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "ICU and duration of Hospital stay", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "In-hospital mortality, 30-days mortality", 
                "safety_issue": "Yes", 
                "time_frame": "30 days"
            }, 
            {
                "measure": "Fluid balance (daily and cumulative)", 
                "safety_issue": "Yes", 
                "time_frame": "3 days"
            }
        ], 
        "source": "University Clinical Center Tuzla", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Clinical Center Tuzla", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}